ISPR
Ispire Technology Inc.
NASDAQ · Consumer Defensive · Tobacco · US
$1.51
−0.99%Year over year
Reported trailing growth
- Revenue
- -38.2%
- EBITDA
- +63.0%
- EBIT
- -26.9%
- EPS
- -24.0%
- Free cash flow
- +26.2%
- Operating cash flow
- +28.6%
Forward estimates
Based on analyst estimates
- Revenue
- +25.9%
- EBITDA
- +106.4%
- EPS
- +93.4%
Three-year CAGR
- Revenue
- +13.1%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +60.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026